Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 203,470 |
|
|||||
| News | - | ||||||
| Day High | 2.7101 | Low High |
|||||
| Day Low | 2.535 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Rezolute Inc | RZLT | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.07 | -2.69% | 2.53 | 18:56:40 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 2.65 | 2.535 | 2.7101 | 2.66 | 2.60 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,553 | 203,470 | US$ 2.64 | US$ 537,306 | - | 0.72 - 3.69 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:47:25 | 27 | US$ 2.53 | USD |
Rezolute Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 105.4M | 39.63M | - | 0 | -51.79M | -1.31 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Rezolute News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RZLT Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.31 | 3.69 | 2.50 | 2.99 | 481,587 | -0.78 | -23.56% |
| 1 Month | 2.68 | 3.69 | 2.22 | 2.93 | 326,911 | -0.15 | -5.60% |
| 3 Months | 0.96 | 3.69 | 0.9199 | 2.07 | 347,485 | 1.57 | 163.54% |
| 6 Months | 1.03 | 3.69 | 0.72 | 1.75 | 228,957 | 1.50 | 145.63% |
| 1 Year | 2.05 | 3.69 | 0.72 | 1.72 | 130,777 | 0.48 | 23.41% |
| 3 Years | 6.77 | 17.39 | 0.72 | 3.28 | 94,262 | -4.24 | -62.63% |
| 5 Years | 20.14 | 21.20 | 0.72 | 3.38 | 82,866 | -17.61 | -87.44% |
Rezolute Description
| Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402. |
